Загрузка...
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
BACKGROUND: There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G)...
Сохранить в:
| Опубликовано в: : | PLoS One |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590912/ https://ncbi.nlm.nih.gov/pubmed/28886099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184178 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|